SUPPLEMENTARY TABLE 2. Prespecified outcomes*,† for recombinant zoster vaccine (RZV) in reports submitted to the Vaccine Adverse Events Reporting System (VAERS) — United States, October 2017–June 2018
Advanced Search
Select up to three search categories and corresponding keywords using the fields to the right. Refer to the Help section for more detailed instructions.
 
 
Help
Clear All
i


SUPPLEMENTARY TABLE 2. Prespecified outcomes*,† for recombinant zoster vaccine (RZV) in reports submitted to the Vaccine Adverse Events Reporting System (VAERS) — United States, October 2017–June 2018

  • Published Date:

    February 28, 2019

  • Source:
    MMWR. Morbidity and mortality weekly report ; v. 68, no. 4
  • Language:
    English
Filetype[PDF-349.78 KB]


Details:
  • Supporting Files:
    No Additional Files

You May Also Like: